Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


JOBS Gets To Work On IPOs, Companies Cherry Pick Benefits

This article was originally published in The Pink Sheet Daily

Executive Summary

The JOBS Act has made it easier for life sciences companies to file to go public and to communicate with potential investors. But the cost savings from reduced regulatory compliance has yet to be fully achieved.


Related Content

On The Road And Through The Window: Inside Three Biotech IPOs
As Some New Listings Thrive, IPO Pipeline Burgeons
Biopharma IPOs Start to Gear Up For 2013 After a Lull
Biopharma IPOs Start To Gear Up For 2013 After A Lull
SEC Outlines What’s Next On JOBS Act
Corporate Investors Boost M&A Step-Ups, But Not IPOs
More And Better Biotech IPOs, But Step-Ups Still Lag


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts